AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results
Authors: Zinzani, PL Stefoni, V Tani, M Barbieri, E Albertini, P Vigna, E Gherlinzoni, F Alinari, L Galuppi, A Pileri, S Babini, L Tura, S
Citation: Pl. Zinzani et al., MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results, LEUK LYMPH, 42(5), 2001, pp. 989-995
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases
Authors: Pileri, SA Zinzani, PL Ascani, S Orcioni, GF Gamberi, B Piccioli, M Sabattini, E Poggi, S Piccaluga, PP Falini, B
Citation: Sa. Pileri et al., Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases, ANN ONCOL, 12(10), 2001, pp. 1445-1453
Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers
Authors: Bendandi, M Tonelli, R Maffei, R Botti, S Turi, C Sartini, R Inoges, S Calvillo, MR Zinzani, PL Pession, A Pileri, SA Paolucci, G
Citation: M. Bendandi et al., Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers, ANN ONCOL, 12(10), 2001, pp. 1479-1484
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia
Authors: Boogaerts, MA Van Hoof, A Catovsky, D Kovacs, M Montillo, M Zinzani, PL Binet, JL Feremans, W Marcus, R Bosch, F Verhoef, G Klein, M
Citation: Ma. Boogaerts et al., Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia, J CL ONCOL, 19(22), 2001, pp. 4252-4258
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas
Authors: Guglielmi, C Martelli, M Federico, M Zinzani, PL Vitolo, U Bellesi, G Santini, G Tarella, C Zallio, F Pregno, P Di Renzo, N Resegotti, L
Citation: C. Guglielmi et al., Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas, HAEMATOLOG, 86(9), 2001, pp. 941-950
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma
Authors: Zinzani, PL Tani, M Stefoni, V Albertini, P Bendandi, M Gherlinzoni, F Alinari, L Vigna, E Tura, S
Citation: Pl. Zinzani et al., Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma, HAEMATOLOG, 86(3), 2001, pp. 287-290
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy
Authors: Zinzani, PL Martelli, M De Renzo, A Zaccaria, A Pavone, E Bocchia, M Falini, B Gobbi, M Gherlinzoni, F Bendandi, M Stefoni, V Tani, M Tura, S
Citation: Pl. Zinzani et al., Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy, HAEMATOLOG, 86(2), 2001, pp. 187-191
Importance of gallium scan restaging for curative treatment of mediastinallymphomas
Authors: Zinzani, PL Monetti, N Zompatori, M Stefoni, V Fanti, S Baccarani, M Tura, S
Citation: Pl. Zinzani et al., Importance of gallium scan restaging for curative treatment of mediastinallymphomas, HAEMATOLOG, 86(11), 2001, pp. 1229-1230
Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia
Authors: Lauria, F Lenoci, M Annino, L Raspadori, D Marotta, G Bocchia, M Forconi, F Gentili, S La Manda, M Marconcini, S Tozzi, M Baldini, L Zinzani, PL Foa, R
Citation: F. Lauria et al., Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia, HAEMATOLOG, 86(10), 2001, pp. 1046-1050
Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems
Authors: Gobbi, PG Zinzani, PL Broglia, C Comelli, M Magagnoli, M Federico, M Merli, F Iannitto, E Tura, S Ascari, E
Citation: Pg. Gobbi et al., Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems, CANCER, 91(8), 2001, pp. 1467-1478
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy
Authors: Pileri, SA Facchetti, F Ascani, S Sabattini, E Poggi, S Piccioli, M Rondelli, D Vergoni, F Zinzani, PL Piccaluga, PP Falini, B Isaacson, PG
Citation: Sa. Pileri et al., Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy, AM J PATH, 159(3), 2001, pp. 915-924
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
Authors: Zinzani, PL Magagnoli, M Bendandi, M Gherlinzoni, F Orcioni, GF Cellini, C Stefoni, V Pileri, SA Tura, S
Citation: Pl. Zinzani et al., Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas, ANN ONCOL, 11(3), 2000, pp. 363-365
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma
Authors: Zinzani, PL Magagnoli, M Moretti, L De Renzo, A Battista, R Zaccaria, A Guardigni, L Mazza, P Marra, R Ronconi, F Lauta, VM Bendandi, M Gherlinzoni, F Gentilini, P Ciccone, F Cellini, C Stefoni, V Ricciuti, F Gobbi, M Tura, S
Citation: Pl. Zinzani et al., Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma, J CL ONCOL, 18(4), 2000, pp. 773-779
Efficacy of rituximab in hairy cell leukemia treatment
Authors: Zinzani, PL Ascani, S Piccaluga, PP Bendandi, M Pileri, S Tura, S
Citation: Pl. Zinzani et al., Efficacy of rituximab in hairy cell leukemia treatment, J CL ONCOL, 18(22), 2000, pp. 3875-3877
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: Experience in 44 patients
Authors: Zinzani, PL Baliva, G Magagnoli, M Bendandi, M Modugno, G Gherlinzoni, F Orcioni, GF Ascani, S Simoni, R Pileri, SA Tura, S
Citation: Pl. Zinzani et al., Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: Experience in 44 patients, J CL ONCOL, 18(13), 2000, pp. 2603-2606
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine
Authors: Zinzani, PL Magagnoli, M Bendandi, M Tani, M Stefoni, V Cellini, C Poggi, S Piccioli, M Pileri, S Tura, S
Citation: Pl. Zinzani et al., Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine, HAEMATOLOG, 85(9), 2000, pp. 922-925
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients
Authors: Zinzani, PL Bendandi, M Stefoni, V Albertini, P Gherlinzoni, F Tani, M Piccaluga, PP Tura, S
Citation: Pl. Zinzani et al., Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients, HAEMATOLOG, 85(9), 2000, pp. 926-929
Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease
Authors: Zinzani, PL Magagnoli, M Bendandi, M Barbieri, E Galuppi, A Gherlinzoni, F Tani, M Albertini, P Stefoni, V Babini, L Tura, S
Citation: Pl. Zinzani et al., Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 729-732
Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma
Authors: Zinzani, PL Bendandi, M Gamberi, B Magagnoli, M Gherlinzoni, F Tura, S
Citation: Pl. Zinzani et al., Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma, HAEMATOLOG, 85(4), 2000, pp. 437-438
Indolent lymphomas
Authors: Tura, S Zinzani, PL
Citation: S. Tura et Pl. Zinzani, Indolent lymphomas, HAEMATOLOG, 85(2), 2000, pp. 113-114
The pathologist's view point. Part I - indolent lymphomas
Authors: Pileri, SA Ascani, S Sabatini, E Fraternali-Orcioni, G Poggi, S Piccioli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part I - indolent lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1291-1307
The pathologist's view point. Part II - aggressive lymphomas
Authors: Pileri, SA Ascani, S Sabattini, E Fraternali-Orcioni, G Poggi, S Piccoli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part II - aggressive lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1308-1321
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia
Authors: Zinzani, PL Bendandi, M Magagnoli, M Albertini, P Rondelli, D Stefoni, V Tani, M Tura, S
Citation: Pl. Zinzani et al., Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia, HAEMATOLOG, 85(11), 2000, pp. 1135-1139
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases
Authors: Federico, M Vitolo, U Zinzani, PL Chisesi, T Clo, V Bellesi, G Magagnoli, M Liberati, M Boccomini, C Niscola, P Pavone, V Cuneo, A Santini, G Brugiatelli, M Baldini, L Rigacci, L Resegotti, L
Citation: M. Federico et al., Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases, BLOOD, 95(3), 2000, pp. 783-789
ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease
Authors: Zinzani, PL Magagnoli, M Frezza, G Barbieri, E Gherlinzoni, F Galuppi, A Bendandi, M Merla, E Albertini, P Tura, S
Citation: Pl. Zinzani et al., ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease, LEUK LYMPH, 32(5-6), 1999, pp. 553-559
Risultati: 1-25 | 26-40